Diabetes Research and Clinical Practice 1998: Vol 39 Index

9 Pages·1998·2.3 MB·English

Diabetes Research and Clinical Practice 39 (1998) 229-231
Author index of volume 39
Abuaisha, B.B., J.B. Costanzi, A.J. Boulton, Acupuncture for Contiero, E., R. Ferrari, G.M. Vaselli, M. Folin, Quantifica-
the treatment of chronic painful peripheral diabetic neu- tion of apolipoprotein Al-containing lipoprotein particles in
ropathy: a long-term study 39, 115 non-insulin-dependent diabetes mellitus 39, 201
Abuaisha, B., S. Kumar, R. Malik, A.J. Boulton, Relationship Costanzi, J.B., see Abuaisha, B.B. 39, 115
of elevated urinary albumin excretion to components of the Cucinotta, D., see Romano, G. 39, 101
metabolic syndrome in non-insulin-dependent diabetes mel- Cuisinier-Raynal, J.C., see Papoz, L. 39, 219
litus 39, 93
Abu Sayeed, M., A. Banu, M.A. Malek, A.K. Azad Khan, Darrack, R., see Papoz, L. 39, 219
Blood pressure and coronary heart disease in NIDDM
Deary, I.J., see Perros, P. 39, 23
subjects at diagnosis: prevalence and risks in a Bangladeshi
DeAtkine, D.D., see Feinglos, M.N. 39, 193
population 39, 147 de la Calle, H., see de Luis, D.A. 39, 143
Agardh, C.-D., see Lévestam-Adrian, M. 39, 11
Delcourt, C., see Papoz, L. 39, 219
Agardh, E., see Lévestam-Adrian, M. 39, 11
de Luis, D.A., H. de la Calle, G. Roy, C. Martin de Argila, S.
Araujo-Vilar, D., C.A. Rega-Liste, D.A. Garcia-Estevez, F.
Valdezate, R. Canton, D. Boixeda, Helicobacter pylori in-
Sarmiento-Escalona, V. Mosquera-Tallon, J. Cabezas-Cer-
fection and insulin-dependent diabetes mellitus 39, 143
rato, Minimal model of glucose metabolism: Modified equa-
Di Benedetto, A., see Romano, G. 39, 101
tions and its application in the study of insulin sensitivity in
Di Cesare, E., see Romano, G. 39, 101
obese subjects 39, 129
Dominguez, E., see Serraclara, A. 39, 19
Araujo-Vilar, D., see Garcia-Estévez, D.A. 39, 107
Azad Khan, A.K., see Abu Sayeed, M. 39, 147
Eibl, N., C. Schnack, M. Frank, G. Schernthaner, Initial
urinary albumin excretion determines the progression of
Babazono, T., see Miura, J. 39, 31
microalbuminuria in patients with type-2 diabetes and nor-
Bandoh, T., see Ishikawa, J. 39, 3
motensive blood pressure values despite improved metabolic
Banu, A., see Abu Sayeed, M. 39, 147
control 39, 39
Boixeda, D., see de Luis, D.A. 39, 143
English, J.S., see Feinglos, M.N. 39, 193
Borgeld, H.-J., see Miura, J. 39, 31
Engstrém, L., see Lundman, B. 39, 157
Boulton, A.J., see Abuaisha, B. 39, 93
Boulton, A.J., see Abuaisha, B.B. 39, 115
Feinglos, M.N., C.R. Thacker, B. Lobaugh, D.D. DeAtkine,
Boulton, A.J., see Shaw, J.E. 39, 55
Bursey, D.L., see Feinglos, M.N. 39, 193 D.B. McNeill, J.S. English, D.L. Bursey, Combination in-
sulin and sulfonylurea therapy in insulin-requiring type 2
Cabezas-Cerrato, J., see Araujo-Vilar, D. 39, 129 diabetes mellitus 39, 193
Cabezas-Cerrato, J., see Garcia-Estévez, D.A. 39, 107 Ferrari, R., see Contiero, E. 39, 201
Califano, L., see Romano, G. 39, 101 Folling, I., see Carlsen, S.M. 39, 47
Campillo, J.E., see Serraclara, A. 39, 19 Folin, M., see Contiero, E. 39, 201
Canton, R., see de Luis, D.A. 39, 143 Frank, M., see Eibl, N. 39, 39
Carlsen, S.M., V. Grill, I. Folling, Evidence for dissociation of Frier, B.M., see Perros, P. 39, 23
insulin- and weight-reducing effects of metformin in non-di- Fujito, T., see Miura, J. 39, 31
abetic male patients with coronary heart disease 39, 47 Fukushima, N., see Yamada, H. 39, 211
0168-8227/97/$19.00 © 1998 Elsevier Science Ireland Ltd. All rights reserved.
PIT S0168-8227(97)00113-7
230 Author index of volume 39
Garcia-Estévez, D.A., D. Aratjo-Vilar, J. Cabezas-Cerrato, Malik, R., see Abuaisha, B. 39, 93
Non-insulin-mediated glucose uptake in several insulin-resis- Martin de Argila, C., see de Luis, D.A. 39, 143
tant states in the postabsortive period 39, 107 Mathai, T., see Viswanathan, V. 39, 63
Garcia-Estevez, D.A., see Araujo-Vilar, D. 39, 129 Matsunaga, R., see Miura, J. 39, 31
Giofré, C., see Romano, G. 39, 101 Matsuura, N., see Yamada, H. 339, 211
Gokal, R., see Shaw, J.E. 39, 55 McNeill, D.B., see Feinglos, M.N. 39, 193
Grasso, G., see Lunetta, M. 39, 165 Mitani, H., see Ishikawa, J. 39, 3
Grill, V., see Carlsen, S.M. 39, 47 Miura, J., see Yamada, H. 39, 211
Miura, J., Y. Uchigata, A. Sato, R. Matsunaga, T. Fujito,
H.-J. Borgeld, M. Tanaka, T. Babazono, C. Takahashi, Y.
Hawkins, F., see Serraclara, A. 39, 19
Hayashi, S., see Ishikawa, J. 39, 3 Iwamoto, An IDDM patient who complained of chest op-
pression with ischemic changes on ECG in insulin-induced
Hellstr6m, S., see Kniola, B. 39, 173
hypoglycemia 39, 31
Hiltunen, L., E. Laara, S.-L. Kivela, S. Keinanen-Kiukaan-
Mizota, M., see Yamada, H. 39, 211
niemi, Glucose tolerance and mortality in an elderly Finnish
Moretti, G., see Romano, G. 39, 101
population 39, 75
Mosquera-Tallon, V., see Araujo-Vilar, D. 39, 129
Hollis, S., see Shaw, J.E. 39, 55
Mutoh, K., see Yamada, H. 39, 211
Ip, T.-P., see Wang, W.-Q. 39, 185
Nagataki, S., see Yamada, H. 39, 211
Ishikawa, J., H. Mitani, T. Bandoh, M. Kimura, T. Totsuka,
S. Hayashi, Hypoglycemic and hypotensive effects of 6-cy-
Omori, Y., see Yamada, H. 39, 211
clohexyl-2’-O-methyl-adenosine, an adenosine A, receptor
Otani, T., see Yamada, H. 39, 211
agonist, in spontaneously hypertensive rat complicated with
hyperglycemia 39, 3
Papoz, L., C. Delcourt, A. Ponton-Sanchez, A. Lokrou, R.
Iwamoto, Y., see Miura, J. 39, 31
Darrack, I.A. Touré, J.C. Cuisinier-Raynal, Clinical classifi-
Iwamoto, Y., see Yamada, H. 39, 211
cation of diabetes in tropical West Africa 39, 219
Payne, C.B., R.S. Scott, Hospital discharges for diabetic foot
Jayaraman, M., see Viswanathan, V. 39, 63
disease in New Zealand: 1980-1993 39, 69
Pérez, C., see Serraclara, A. 39, 19
Kasahara, T., see Yamada, H. 39, 211
Perros, P., I.J. Deary, B.M. Frier, Factors influencing prefer-
Kawasaki, E., see Yamada, H. 39, 211
ence of insulin regimen in people with type 1 (insulin—de-
Keinanen-Kiukaanniemi, S., see Hiltunen, L. 39, 75
pendent) diabetes 39, 23
Kimura, M., see Ishikawa, J. 39, 3
Ponton-Sanchez, A., see Papoz, L. 39, 219
Kivela, S.-L., see Hiltunen, L. 39, 75
Kniola, B., S. Hellstr6m, J. Ludvigsson, Islet cell surface
Rajbhandari, S.M., R.M. Wilson, Unusual infections in dia-
antibodies (ICSA) do bind to human pancreas: computer-
betes 39, 123
ised, quantitative determination of ICSA using both pre-
Ramachandran, A., see Viswanathan, V. 39, 63
and postembedding immunocolloidal techniques 39, 173
Rega-Liste, C.A., see Araujo-Vilar, D. 39, 129
Koike, A., see Yamada, H. 39, 211
Romano, G., G. Moretti, A. Di Benedetto, C. Giofré, E. Di
Kubo, H., see Yamada, H. 39, 211
Cesare, G. Russo, L. Califano, D. Cucinotta, Skin lesions in
Kumar, S., see Abuaisha, B. 39, 93
diabetes mellitus: prevalence and clinical correlations 39,
101
Laara, E., see Hiltunen, L. 39, 75 Roy, G., see de Luis, D.A. 39, !43
Lam, K.S., see Wang, W.-Q. 39, 185
Russo, G., see Romano, G. 39, 101
Le Moli, R., see Lunetta, M. 39, 165
Lobaugh, B., see Feinglos, M.N. 39, 193
Sangiorgio, L., see Lunetta, M. 39, 165
Lokrou, A., see Papoz, L. 39, 219
Sarmiento-Escalona, F., see Araujo-Vilar, D. 39, 129
Lévestam-Adrian, M., E. Agardh, C.-D. Agardh, The inci- Sato, A., see Miura, J. 39, 31
dence of nephropathy in type | diabetic patients with prolif-
Sato, A., see Yamada, H. 39, 211
erative retinopathy: a 10-year follow-up study 39, 11 Schernthaner, G., see Eibl, N. 39, 39
Ludvigsson, J., see Kniola, B. 39, 173
Schnack, C., see Eibl, N. 39, 39
Lundman, B., L. Engstrém, Diabetes and it’s complications in Scott, R.S., see Payne, C.B. 39, 69
a Swedish county 39, 157 Serraclara, A., F. Hawkins, C. Pérez, E. Dominguez, J.E.
Lunetta, M., R. Le Moli, G. Grasso, L. Sangiorgio, A sim- Campillo, M.D. Torres, Hypoglycemic action of an oral
plified diagnostic test for ambulatory screening of peripheral fig-leaf decoction in type-I diabetic patients 39, 19
diabetic neuropathy 39, 165 Shaw, J.E., R. Gokal, S. Hollis, A.J. Boulton, Does peripheral
neuropathy invariably accompany nephropathy in type 1
Malek, M.A., see Abu Sayeed, M. 39, 147 diabetes mellitus? 39, 55
Author index of volume 39 231
Snehalatha, C., see Viswanathan, V. 39, 63 A. Ramachandran, Cardio vascular morbidity in proteinuric
South Indian NIDDM patients 39, 63
Takahashi, C., see Miura, J. 39, 31
Tanaka, M., see Miura, J. 39, 31 Wang, W.-Q., T.-P. Ip, K.S. Lam, Changing prevalence of
Thacker, C.R., see Feinglos, M.N. 39, 193 retinopathy in newly diagnosed non-insulin dependent dia-
Torres, M.D., see Serraclara, A. 39, 19 betes mellitus patients in Hong Kong 339, 185
Totsuka, T., see Ishikawa, J. 39, 3 Wilson, R.M., see Rajbhandari, S.M. 39, 123
Touré, I.A., see Papoz, L. 39, 219
Yamada, H., Y. Uchigata, E. Kawasaki, N. Matsuura, T.
Uchigata, Y., see Miura, J. 39, 31 Otani, A. Sato, K. Mutoh, T. Kasahara, N. Fukushima, A.
Uchigata, Y., see Yamada, H. 39, 211 Koike, M. Mizota, J. Miura, H. Kubo, A. Yamaguchi, S.
Nagataki, Y. Omori, Y. Iwamoto, Onset age-dependent
Valdezate, S., see de Luis, D.A. 39, 143 variations of three islet specific autoantibodies in Japanese
Vaselli, G.M., see Contiero, E. 39, 201 IDDM patients 39, 211
Viswanathan, V., C. Snehalatha, T. Mathai, M. Jayaraman, Yamaguchi, A., see Yamada, H. 339, 211

Diabetes Research and Clinical Practice 39 (1998) 233-236
Subject index of volume 39
Acromegaly; Non-insulin mediated glucose uptake; Diabetes CHD; Blood pressures NIDDM; BMI; WHR; Relative
mellitus; Obesity; Cushing’s disease 39, 107 risk 39, 147
Acupuncture; Diabetes mellitus; Painful peripheral neuropa- Classification; Diabetes mellitus; C-peptide; Africa; Epidemiol-
thy 39, 115 ogy 39, 219
Adenosine analogue; Spontaneously hypertensive rat; Hyper- Colloidal gold; Autoantibodies; IDDM; RIA; Quantification;
glycemia; Glucose; Free fatty acid; Triglyceride 39, 3 Human pancreas 39, 173
Africa; Diabetes mellitus; Classification; C-peptide; Epidemiol- C-peptide; Diabetes mellitus; Classification; Africa; Epidemiol-
ogy 39, 219 ogy 39, 219
Aged; Diabetes; Follow-up study; Glucose tolerance; Mortal- Cushing’s disease; Non-insulin mediated glucose uptake; Dia-
ity; Prognosis 39, 75 betes mellitus; Obesity; Acromegaly 39, 107
Apolipoprotein AlI-containing particles; Atherosclerotic risk; Diabetes; Aged; Follow-up study; Glucose tolerance; Mortal-
Electroimmunoassay; High density lipoprotein subfractions;
ity; Prognosis 39, 75
Non-insulin-dependent diabetes mellitus 39, 201
Diabetes; Ficus carica; Hyperglycemia; Hypoglycemic ac-
Atherosclerotic risk; Apolipoprotein Al-containing particles;
tion 39, 19
Electroimmunoassay; High density lipoprotein subfractions;
Non-insulin-dependent diabetes mellitus 39, 201 Diabetes mellitus; Acupuncture; Painful peripheral neuropa-
thy 39, 115
Autoantibodies; IDDM; RIA; Colloidal gold; Quantification;
Human pancreas 39, 173 Diabetes mellitus; Classification; C-peptide; Africa; Epidemiol-
ogy 39, 219
Basal-bolus insulin regimen; Type | (insulin—dependent) dia-
betes mellitus; Insulin; Personality; Treatment satisfac- Diabetes mellitus; Diabetic neuropathy; Diabetic nephropathy;
tion 39, 23 Renal transplantation 39, 55
Blood pressures CHD; NIDDM; BMI; WHR; Relative Diabetes mellitus; Diabetic neuropathy; Neuropathy screening
risk 39, 147 instrument; Diabetic neuropathy score 39, 165
BMI; Blood pressures CHD; NIDDM; WHR; Relative Diabetes mellitus; Helicobacter pylori seroprevalence; Patho-
risk 39, 147 genesis 39, 143
Cardiovascular disease; Metformin; Insulin resistance; Weight Diabetes mellitus; Infection; Malignant otitis externa; Necrotis-
reduction 39, 47 ing-fascitis; Psoas abscess; Fournier’s gangrene 39, 123
Cardiovascular morbidity; Proteinuria; NIDDM; Hyperten- Diabetes mellitus; Non-insulin mediated glucose uptake; Obe-
sion 39, 63 sity; Acromegaly; Cushing’s disease 39, 107
0168-8227/97/$19.00 © 1998 Elsevier Science Ireland Ltd. All rights reserved.
PIT $0168-8227(97)00114-9
234 Subject index of volume 39
High density lipoprotein subfractions; Apolipoprotein Al-con-
Diabetes mellitus; Skin lesions; IDDM; NIDDM; Metabolic
taining particles; Atherosclerotic risk; Electroimmunoassay;
control 39, 101
Non-insulin-dependent diabetes mellitus 39, 201
Diabetes; Prevalence; Retinopathy; Nephropathy; Loss of
pallesthesia macrovascular complications 39, 157 Hospital admissions; Diabetic foot 39, 69
Diabetic foot; Hospital admissions 39, 69 Human pancreas; Autoantibodies; IDDM; RIA; Colloidal
gold; Quantification 39, 173
Diabetic nephropathy; Diabetic neuropathy; Diabetes mellitus;
Renal transplantation 39, 55
Hyperglycemia; Adenosine analogue; Spontaneously hyperten-
sive rat; Glucose; Free fatty acid; Triglyceride 39, 3
Diabetic neuropathy; Diabetic nephropathy; Diabetes mellitus;
Renal transplantation 39, 55
Hyperglycemia; Diabetes; Ficus carica; Hypoglycemic ac-
tion 39, 19
Diabetic neuropathy; Neuropathy screening instrument; Dia-
betic neuropathy score; Diabetes mellitus 39, 165
Hypertension; Cardiovascular morbidity; Proteinuria;
Diabetic neuropathy score; Diabetic neuropathy; Neuropathy NIDDM _ 39, 63
screening instrument; Diabetes mellitus 39, 165
Hypertension; Type-2 diabetes; Metabolic control; Microalbu-
Electroimmunoassay; Apolipoprotein Al-containing particles; minuria 39, 39
Atherosclerotic risk; High density lipoprotein subfractions;
Non-insulin-dependent diabetes mellitus 39, 201 Hypoglycemia; Myocardial ischemia; IDDM; Mitochondrial
gene 39, 31
Elevated urinary albumin excretion rate; Non-insulin-dependent
diabetes mellitus; Metabolic syndrome; Ethnic differences 39, Hypoglycemic action; Diabetes; Ficus carica; Hyper-
93 glycemia 39, 19
Epidemiology; Diabetes mellitus; Classification; C-peptide;
IDDM; Autoantibodies; RIA; Colloidal gold; Quantification;
Africa 39, 219 Human pancreas 39, 173
Ethnic differences; Non-insulin-dependent diabetes mellitus;
IDDM; Hypoglycemia; Myocardial ischemia; Mitochondrial
Elevated urinary albumin excretion rate; Metabolic syn-
gene 39, 31
drome 39, 93
IDDM; Skin lesions; Diabetes mellitus; NIDDM; Metabolic
Ficus carica; Diabetes; Hyperglycemia; Hypoglycemic ac-
control 39, 101
tion 39, 19
Infection; Diabetes mellitus; Malignant otitis externa; Necrot-
Follow-up study; Aged; Diabetes; Glucose tolerance; Mortality;
ising-fascitis; Psoas abscess; Fournier’s gangrene 39, 123
Prognosis 39, 75
Insulin resistance; Metformin; Cardiovascular disease; Weight
Fournier’s gangrene; Diabetes mellitus; Infection; Malignant
reduction 39, 47
otitis externa; Necrotising-fascitis; Psoas abscess 39, 123
Insulin sensitivity; Minimal model; Glucose effectiveness; Inter-
Free fatty acid; Adenosine analogue; Spontaneously hyperten-
stitial insulin; Obesity 39, 129
sive rat; Hyperglycemia; Glucose; Triglyceride 39, 3
Glucose; Adenosine analogue; Spontaneously hypertensive rat; Insulin; Type 2 diabetes mellitus; Sulfonylurea 39, 193
Hyperglycemia; Free fatty acid; Triglyceride 39, 3
Insulin; Type 1 (insulin—dependent) diabetes mellitus; Person-
Glucose effectiveness; Minimal model; Insulin sensitivity; Inter- ality; Treatment satisfaction; Basal-bolus insulin regimen 339,
stitial insulin; Obesity 39, 129 23
Glucose tolerance; Aged; Diabetes; Follow-up study; Mortal- Interstitial insulin; Minimal model; Insulin sensitivity; Glucose
ity; Prognosis 39, 75 effectiveness; Obesity 39, 129
Helicobacter pylori seroprevalence; Diabetes mellitus; Patho- Loss of pallesthesia macrovascular complications; Prevalence;
genesis 39, 143 Diabetes; Retinopathy; Nephropathy 39, 157
Subject index of volume 39 235
Malignant otitis externa; Diabetes mellitus; Infection; Necrot- Non-insulin-dependent diabetes mellitus; Apolipoprotein AI-
ising-fascitis; Psoas abscess; Fournier’s gangrene 39, 123 containing particles; Atherosclerotic risk; Electroim-
munoassay; High density lipoprotein subfractions 39, 201
Metabolic control; Skin lesions; Diabetes mellitus; IDDM;
NIDDM _ 39, 101 Non-insulin-dependent diabetes mellitus; Elevated urinary albu-
min excretion rate; Metabolic syndrome; Ethnic differ-
Metabolic control; Type-2 diabetes; Microalbuminuria; Hyper- ences 39, 93
tension 39, 39
Non-insulin dependent diabetes mellitus; Retinopathy;
Metabolic syndrome; Non-insulin-dependent diabetes mellitus; Nephropathy; Neuropathy; Prevalence 39, 185
Elevated urinary albumin excretion rate; Ethnic differ-
ences 39, 93 Non-insulin mediated glucose uptake; Diabetes mellitus; Obe-
sity; Acromegaly; Cushing’s disease 39, 107
Metformin; Cardiovascular disease; Insulin resistance; Weight
reduction 39, 47 Obesity; Minimal model; Insulin sensitivity; Glucose effective-
ness; Interstitial insulin 39, 129
Microalbuminuria; Type-2 diabetes; Metabolic control; Hyper-
tension 39, 39
Obesity; Non-insulin mediated glucose uptake; Diabetes melli-
tus; Acromegaly; Cushing’s disease 39, 107
Minimal model; Insulin sensitivity; Glucose effectiveness; Inter-
stitial insulin; Obesity 39, 129
Painful peripheral neuropathy; Diabetes mellitus; Acupunc-
ture 39, 115
Mitochondrial gene; Hypoglycemia; Myocardial ischemia;
IDDM _ 39, 31
Pathogenesis; Helicobacter pylori seroprevalence; Diabetes
mellitus 39, 143
Mortality; Aged; Diabetes; Follow-up study; Glucose toler-
ance; Prognosis 39, 75
Personality; Type | (insulin—dependent) diabetes mellitus; In-
sulin; Treatment satisfaction; Basal-bolus insulin regimen 339,
Myocardial ischemia; Hypoglycemia; IDDM; Mitochondrial
23
gene 39, 31
Prevalence; Diabetes; Retinopathy; Nephropathy; Loss of
Necrotising-fascitis; Diabetes mellitus; Infection; Malignant
pallesthesia macrovascular complications 39, 157
otitis externa; Psoas abscess; Fournier’s gangrene 39, 123
Prevalence; Non-insulin dependent diabetes mellitus;
Nephropathy; Non-insulin dependent diabetes mellitus;
Retinopathy; Nephropathy; Neuropathy 39, 185
Retinopathy; Neuropathy; Prevalence 39, 185
Prognosis; Aged; Diabetes; Follow-up study; Glucose toler-
Nephropathy; Prevalence; Diabetes; Retinopathy; Loss of
ance; Mortality 39, 75
pallesthesia macrovascular complications 39, 157
Proliferative retinopathy; Nephropathy; Type | diabetes 39,
Nephropathy; Proliferative retinopathy; Type 1 diabetes 39,
11
1]
Proteinuria; Cardiovascular morbidity; NIDDM; Hyperten-
Neuropathy; Non-insulin dependent diabetes mellitus;
Retinopathy; Nephropathy; Prevalence 39, 185 sion 39, 63
Neuropathy screening instrument; Diabetic neuropathy; Dia- Psoas abscess; Diabetes mellitus; Infection; Malignant otitis
externa; Necrotising-fascitis; Fournier’s gangrene 39, 123
betic neuropathy score; Diabetes mellitus 39, 165
NIDDM; Blood pressure; CHD; BMI; WHR; Relative Quantification; Autoantibodies; IDDM; RIA; Colloidal gold;
risk 39, 147 Human pancreas 39, 173
NIDDM; Cardiovascular morbidity; Proteinuria; Hyperten- Relative risk; Blood pressures CHD; NIDDM; BMI;
sion 39, 63 WHR _ 39, 147
NIDDM; Skin lesions; Diabetes mellitus; IDDM; Metabolic Renal transplantation; Diabetic neuropathy; Diabetic
control 39, 101 nephropathy; Diabetes mellitus 39, 55
236 Subject index of volume 39
Retinopathy; Non-insulin dependent diabetes mellitus; Triglyceride; Adenosine analogue; Spontaneously hypertensive
Nephropathy; Neuropathy; Prevalence 39, 185 rat; Hyperglycemia; Glucose; Free fatty acid 39, 3
Retinopathy; Prevalence; Diabetes; Nephropathy; Loss of Type 2 diabetes mellitus; Sulfonylurea; Insulin 39, 193
pallesthesia macrovascular complications 39, 157
Type-2 diabetes; Metabolic control; Microalbuminuria; Hyper-
RIA; Autoantibodies; IDDM; Colloidal gold; Quantification; tension 39, 39
Human pancreas 39, 173
Type 1 diabetes; Proliferative retinopathy; Nephropathy 339,
Skin lesions; Diabetes mellitus; IDDM; NIDDM; Metabolic 1]
control 39, 101
Type 1 (insulin—dependent) diabetes mellitus; Insulin; Personal-
Spontaneously hypertensive rat; Adenosine analogue; Hyper- ity; Treatment satisfaction; Basal-bolus insulin regimen 339,
glycemia; Glucose; Free fatty acid; Triglyceride 39, 3 23
Sulfonylurea; Type 2 diabetes mellitus; Insulin 39, 193 Weight reduction; Metformin; Cardiovascular disease; Insulin
resistance 39, 47
Treatment satisfaction; Type 1 (insulin—dependent) diabetes
mellitus; Insulin; Personality; Basal-bolus insulin regimen 339, WHR; Blood pressures CHD; NIDDM; BMI; Relative
23 risk 39, 147